RI
GBT

RTW Investments’s Global Blood Therapeutics, Inc. GBT Stock Holding History

RTW Investments’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-719,489
Closed -$36.8M – 81
2020
Q1 		$36.8M Buy
+719,489
New +$48.2M 1.58% 21
2018
Q2 		– Sell
-456,921
Closed -$22.1M – 43
2018
Q1 		$22.1M Sell
456,921
-144,762
-24% -$8.07M 2.1% 13
2017
Q4 		$23.7M Buy
601,683
+575,373
+2,187% +$21.5M 3.95% 10
2017
Q3 		$817K Sell
26,310
-67
-0.3% -$1.88K 0.14% 25
2017
Q2 		$721K Buy
26,377
+194
+0.7% +$5.77K 0.15% 25
2017
Q1 		$965K Buy
26,183
+220
+0.8% +$5.54K 0.25% 23
2016
Q4 		$375K Sell
25,963
-69,751
-73% -$1.23M 0.14% 27
2016
Q3 		$2.21M Sell
95,714
-1,424
-1% -$27.1K 0.67% 26
2016
Q2 		$1.61M Sell
97,138
-93,843
-49% -$1.89M 0.55% 25
2016
Q1 		$3.03M Buy
190,981
+15,825
+9% +$281K 1.1% 20
2015
Q4 		$5.66M Buy
175,156
+82,757
+90% +$3.58M 1.84% 16
2015
Q3 		$3.9M Buy
+92,399
New +$4.36M 1.21% 20

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

RTW Investments's GBT Position: Q2 2020 in Review

RTW Investments sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2020, closing a stake of 719,489 shares — an estimated $36.8M sold.

RTW Investments first reported a position in GBT in Q3 2015 and held it in 12 quarters. The position peaked at $36.8M in Q1 2020. 253 funds tracked by Wall St. Rank hold GBT as of Q2 2020.

  • RTW Investments reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • RTW Investments sold 719,489 Global Blood Therapeutics, Inc. shares in Q2 2020, an estimated $36.8M.
  • RTW Investments first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 12 quarters.
  • RTW Investments's Global Blood Therapeutics, Inc. position peaked at $36.8M in Q1 2020.
  • 253 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2020.

Based on RTW Investments's 13F filing for Q2 2020, filed 14 Aug 2020.